INNOVUS PHARMACEUTICALS, INC. Share-based Payment Arrangement, Expense
INNOVUS PHARMACEUTICALS, INC. reported Share-based Payment Arrangement, Expense of $225.17 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2017-05-15
- INNOVUS PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2017-03-31 was $225.17K, a 57.08% decline year-over-year.
- INNOVUS PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2016-06-30 was $111.89K, a 7.68% decline year-over-year.
- INNOVUS PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2016-03-31 was $524.63K, a 16.79% decline year-over-year.
- INNOVUS PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2015-12-31 was $466.19K, a 99.97% decline year-over-year.
- INNOVUS PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2016 was $954.00K, a 26.50% decline from fiscal 2015.
- INNOVUS PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2015 was $1.30M, a 99.91% decline from fiscal 2014.
- INNOVUS PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2014 was $1.51B, a 33.08% decline from fiscal 2013.
- INNOVUS PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2013 was $2.25B.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-03-31 | $225.17K 10-Q · filed 2017-05-15 | |||||
| 2016-12-31 | $954.00K 10-K · filed 2017-03-09 | |||||
| 2016-06-30 | $111.89K 10-Q · filed 2016-08-15 | $636.52K 10-Q · filed 2016-08-15 | $1.10M derived: sum of 3 quarters · filed 2017-05-15 | $1.18M derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2016-03-31 | $524.63K 10-Q · filed 2017-05-15 | $990.83K derived: sum of 2 quarters · filed 2017-05-15 | $1.07M derived: sum of 3 quarters · filed 2017-05-15 | $1.19M derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2015-12-31 | $466.19K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $546.29K derived: sum of 2 quarters · filed 2017-03-09 | $667.48K derived: sum of 3 quarters · filed 2017-03-09 | $1.30M 10-K · filed 2017-03-09 | $1.30B 10-K · filed 2016-03-30 | |
| 2015-09-30 | $80.10K 10-Q · filed 2015-11-16 | $201.29K derived: sum of 2 quarters · filed 2016-08-15 | $831.81K 10-Q · filed 2015-11-16 | $1.51B derived: sum of 4 quarters · filed 2016-08-15 | ||
| 2015-06-30 | $121.19K 10-Q · filed 2016-08-15 | $121.55K 10-Q · filed 2015-08-14 | $751.71K 10-Q · filed 2016-08-15 | $1.51B derived: sum of 3 quarters · filed 2016-08-15 | $1.51B derived: sum of 4 quarters · filed 2016-08-15 | |
| 2015-03-31 | $630.52K 10-Q · filed 2016-05-16 | $1.51B derived: sum of 2 quarters · filed 2016-05-16 | $1.51B derived: sum of 3 quarters · filed 2016-05-16 | $1.51B derived: sum of 4 quarters · filed 2016-05-16 | ||
| 2014-12-31 | $1.51B derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $1.51B derived: sum of 2 quarters · filed 2016-03-30 | $1.51B derived: sum of 3 quarters · filed 2016-03-30 | $1.51B 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $282.95K 10-Q · filed 2015-11-16 | $282.95K 10-Q · filed 2014-11-14 | $644.89K derived: sum of 2 quarters · filed 2015-11-16 | $1.21M 10-Q · filed 2015-11-16 | $2.26B derived: sum of 4 quarters · filed 2015-11-16 | |
| 2014-06-30 | $361.94K 10-Q · filed 2015-08-14 | $926.16K 10-Q · filed 2015-08-14 | $2.26B derived: sum of 3 quarters · filed 2015-08-14 | $2.26B derived: sum of 4 quarters · filed 2015-08-14 | ||
| 2014-03-31 | $654.23K 10-Q · filed 2015-05-15 | $564.23K 10-Q · filed 2014-05-14 | $2.26B derived: sum of 2 quarters · filed 2015-05-15 | $2.26B derived: sum of 3 quarters · filed 2015-05-15 | $2.26B derived: sum of 4 quarters · filed 2015-05-15 | |
| 2013-12-31 | $2.25B derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $2.26B derived: sum of 2 quarters · filed 2015-03-31 | $2.26B derived: sum of 3 quarters · filed 2015-03-31 | $2.25B 10-K · filed 2015-03-31 | ||
| 2013-09-30 | $962.38K 10-Q · filed 2014-11-14 | $2.58M derived: sum of 2 quarters · filed 2014-11-14 | $289.27K 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | $1.61M 10-Q · filed 2014-08-14 | $1.68M 10-Q · filed 2014-08-14 | ||||
| 2013-03-31 | $3.75K 10-Q · filed 2014-05-14 |